Peter Greenleaf
Affiliations
- Chief Executive Officer at Aurinia Pharmaceuticals Inc. (AUPH), 2025-03-05
- Director at Antares Pharma Inc. (ATRS), 2022-05-26
- Director at Biodelivery Sciences International Inc (BDSI), 2022-03-22
- Director at Cerecor Inc. (CERC), 2019-10-03
- Director at Eyegate Pharmaceuticals Inc (EYEG), 2019-02-05
- Chief Executive Officer at Sucampo Pharmaceuticals Inc. (SCMP), 2018-02-13
- Director at Mast Therapeutics Inc. (MSTX), 2017-01-23
- Director at Mirna Therapeutics Inc. (MIRN), 2016-09-06
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| AUPH | $11.11 | 2,992 | $33,241.12 | 13,453 | 2021-05-11 | Filing |
| AUPH | $10.15 | 2,133 | $21,649.95 | 10,461 | 2021-05-11 | Filing |
| CERC | $3.98 | 12,500 | $49,750.00 | 412,500 | 2018-05-18 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| AUPH | $7.92 | 164,947 | $1,306,380.24 | 1,788,945 | 2025-03-04 | Filing |
| AUPH | $8.00 | 195,593 | $1,564,744.00 | 1,953,892 | 2025-03-03 | Filing |
| AUPH | $5.60 | 126,981 | $711,093.60 | 1,522,114 | 2024-03-06 | Filing |
| AUPH | $8.78 | 33,047 | $290,152.66 | 982,671 | 2023-03-02 | Filing |
| AUPH | $8.94 | 32,750 | $292,785.00 | 982,968 | 2023-03-02 | Filing |